Generic placeholder image

Recent Patents on Anti-Infective Drug Discovery


ISSN (Print): 1574-891X
ISSN (Online): 2212-4071

Current Developments in Therapeutic and Diagnostic Strategies for Q Fever: Glimpses of Patent Analysis

Author(s): Rashi Chauhan, Gulshan Wadhwa, Sanjeev K. Sharma and Chakresh K. Jain

Volume 9, Issue 2, 2014

Page: [104 - 111] Pages: 8

DOI: 10.2174/1574891X09666141114222644

Price: $65


Coxiella burnetii is an infectious and etiological agent responsible for causing Q fever. There are mainly two forms of the Q fever that are chronic and acute. Though the acute type is usually linked with symptoms like pneumonia and hepatitis, the chronic form is shown to have mortality rate of 5%. Percentage of mortality rate might increases from 5% to 25% if left untreated. The present treatments of disease include the recommended dose of drugs and vaccine. Presently, extensive attempt is in progress to find novel therapies to combat the disease. This review is projected to provide a brief introduction of C. burnetii and Q fever while emphasizing therapeutics, prophylactic measures and diagnostic applications based on recent patents prospects.

Keywords: Antibodies, Coxiella burnetii, doxycycline, fluoroquinolone, therapeutics, vaccines.

Next »
Graphical Abstract

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy